0001144204-14-067937.txt : 20141114 0001144204-14-067937.hdr.sgml : 20141114 20141113185258 ACCESSION NUMBER: 0001144204-14-067937 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20141114 DATE AS OF CHANGE: 20141113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CALMARE THERAPEUTICS Inc CENTRAL INDEX KEY: 0000102198 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 362664428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-190069 FILM NUMBER: 141219806 BUSINESS ADDRESS: STREET 1: 1375 KINGS HIGHWAY EAST CITY: FAIRFIELD STATE: CT ZIP: 06824 BUSINESS PHONE: (203) 368-6044 MAIL ADDRESS: STREET 1: 1375 KINGS HIGHWAY EAST CITY: FAIRFIELD STATE: CT ZIP: 06824 FORMER COMPANY: FORMER CONFORMED NAME: COMPETITIVE TECHNOLOGIES INC DATE OF NAME CHANGE: 19941227 FORMER COMPANY: FORMER CONFORMED NAME: UNIVERSITY PATENTS INC DATE OF NAME CHANGE: 19920703 RW 1 v394128_rw.htm FORM RW

 

Calmare Therapeutics Incorporated

1375 Kings Highway East

Fairfield, CT 06824 33321

 

November 13, 2014

 

 

VIA EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

Re:Calmare Therapeutics Incorporated

Registration Statement on Form S-1

Filed July 22, 2013

File No. 333- 190069

 

Ladies and Gentlemen:

 

Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”), Calmare Therapeutics Incorporated (the “Company”) requests the withdrawal of the Company’s Registration Statement on Form S-1 originally filed on July 22, 2013, File No. 333-190069 (the “S-1 Registration Statement”). The Company has elected to withdraw the S-1 Registration Statement because it does not want to pursue an offering at this time. No sales of the Company’s common stock have been or will be made pursuant to the S-1 Registration Statement.

 

The Company requests that in accordance with Rule 457(p) under the Act, all fees paid to the Commission in connection with the filing of the above-captioned registration statement be credited for future use. If you have any questions regarding this request for withdrawal, please contact our legal counsel, Gregg E. Jaclin at (609) 275-0400.

 

Sincerely,

 

Calmare Therapeutics Incorporated

  

By:  /s/ Conrad Mir  
Name: Conrad Mir  
Title: Chief Executive Officer